119th Congress · introduced in the House · Apr 8, 2025
Protecting American Families and Servicemembers from Anthrax Act
Official title from Congress.gov
Latest action (Apr 8, 2025): Referred to the Committee on Armed Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Armed Forces and National Security
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Armed Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Armed Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
20 citations.
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$260,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act S. 4784, National Defense Authorization Act for Fiscal Year 2027 H.R. 8800, National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$260,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act S. 4784, National Defense Authorization Act for Fiscal Year 2027 H.R. 8800, National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPUTICS · lobbying firm or registrant: HORIZONS GLOBAL SOLUTIONS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 19, 2026 · issue area: Health Issues
$19,000
Paid to lobbying firm
Strategic National Stockpile readiness; H.R. 2707 Protecting American Families and Servicemembers from Anthrax Act: To develop a modernized strategy for ensuring the defense of the United States from the anthr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Defense
$280,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act S. 4784, National Defense Authorization Act for Fiscal Year 2027 H.R. 8800, National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Health Issues
$280,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act S. 4784, National Defense Authorization Act for Fiscal Year 2027 H.R. 8800, National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPUTICS · lobbying firm or registrant: HORIZONS GLOBAL SOLUTIONS LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 13, 2026 · issue area: Health Issues
$19,000
Paid to lobbying firm
Strategic National Stockpile readiness; H.R. 2707 Protecting American Families and Servicemembers from Anthrax Act: To develop a modernized strategy for ensuring the defense of the United States from the anthr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Defense
$220,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$220,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPUTICS · lobbying firm or registrant: HORIZONS GLOBAL SOLUTIONS LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 8, 2026 · issue area: Health Issues
$140,000
Paid to lobbying firm
Strategic National Stockpile readiness; H.R. 2707 Protecting American Families and Servicemembers from Anthrax Act: To develop a modernized strategy for ensuring the defense of the United States from the anthr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPUTICS · lobbying firm or registrant: HORIZONS GLOBAL SOLUTIONS LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · amended · posted Feb 11, 2026 · issue area: Health Issues
$19,000
Paid to lobbying firm
Strategic National Stockpile readiness; H.R. 2707 Protecting American Families and Servicemembers from Anthrax Act: To develop a modernized strategy for ensuring the defense of the United States from the anthr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 21, 2026 · issue area: Defense
$200,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 21, 2026 · issue area: Health Issues
$200,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 21, 2025 · issue area: Defense
$150,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 21, 2025 · issue area: Health Issues
$150,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPUTICS · lobbying firm or registrant: HORIZONS GLOBAL SOLUTIONS LLC
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 9, 2025 · issue area: Health Issues
$19,000
Paid to lobbying firm
Strategic National Stockpile readiness; H.R. 2707 Protecting American Families and Servicemembers from Anthrax Act: To develop a modernized strategy for ensuring the defense of the United States from the anthr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Defense
$220,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazard…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Health Issues
$220,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazard…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPUTICS · lobbying firm or registrant: HORIZONS GLOBAL SOLUTIONS LLC
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 11, 2025 · issue area: Health Issues
$25,000
Paid to lobbying firm
Strategic National Stockpile readiness; H.R. 2707 Protecting American Families and Servicemembers from Anthrax Act: To develop a modernized strategy for ensuring the defense of the United States from the anthr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 21, 2025 · issue area: Defense
$200,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazard…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. · lobbying firm or registrant: ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 21, 2025 · issue area: Health Issues
$200,000
Spent on own lobbying
H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazard…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing